()

(NEW YORK)Shares of the biopharmaceutical company Tercica Inc. soared 99.55 percent on Thursday after it agreed to be purchased by the French firm Ipsen SA for $9 a share or $663 million.READ MORE

(NEW YORK)Shares of Tercica Inc. nearly doubled in value Thursday afternoon after the biopharmaceutical company said it will be bought by Ipsen SA in a cash deal valuing the company at $9 pe...READ MORE

(NEW YORK)Stocks that moved substantially or traded heavily Thursday on the New York Stock Exchange and Nasdaq Stock Market: NYSEREAD MORE

Among the stock activity stories for Thursday, June 5, from AP Financial News: NEW YORK (AP)--Shares of Tercica Inc. nearly doubled in value Thursday afternoon after the biopharmac...READ MORE

(BRISBANE, Calif.)Biopharmaceutical company Tercica Inc. Wednesday said it agreed to be acquired by French drug maker Ipsen SA in a cash transaction valuing Tercica at $663 million.READ MORE

Among the earnings stories for Tuesday, May 13, from AP Financial News: SANTA CLARA, Calif. (AP) _ Chip manufacturing equipment maker Applied Materials Inc. said Tuesday its fiscal...READ MORE

(NEW YORK)Shares of Tercica Inc. fell to their lowest price in almost two years Tuesday after the biopharmaceutical company posted disappointing first-quarter results, including weak sales o...READ MORE